Structure of the multidrug resistance efflux transporter EmrE from Escherichia coli
AUTOR(ES)
Ma, Che
FONTE
National Academy of Sciences
RESUMO
Multidrug resistance efflux transporters threaten to reverse the progress treating infectious disease by extruding a wide range of drug and other cytotoxic compounds. One such drug transporter, EmrE, from the small multidrug resistance family, utilizes proton gradients as an energy source to drive substrate translocation. In an effort to understand the molecular structural basis of this transport mechanism, we have determined the structure of EmrE from Escherichia coli to 3.8 Å. EmrE is a tetramer comprised of two conformational heterodimers related by a pseudo two-fold symmetry axis perpendicular to the cell membrane. Based on the structure and biochemical evidence, we propose a mechanism by which EmrE accomplishes multidrug efflux by coupling conformational changes between two heterodimers with proton gradient. Because of its simplicity and compact size, the structure of EmrE can serve as an ideal model for understanding the general structural basis of proton:drug antiport for other drug efflux systems.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=365709Documentos Relacionados
- The projection structure of EmrE, a proton-linked multidrug transporter from Escherichia coli, at 7 Å resolution
- Three-dimensional structure of the bacterial multidrug transporter EmrE shows it is an asymmetric homodimer
- EmrE, a Small Escherichia coli Multidrug Transporter, Protects Saccharomyces cerevisiae from Toxins by Sequestration in the Vacuole
- A membrane-embedded glutamate is required for ligand binding to the multidrug transporter EmrE
- Thiolactomycin resistance in Escherichia coli is associated with the multidrug resistance efflux pump encoded by emrAB.